Roche receives U.S. emergency approval for coronavirus vs. flu check
A photograph displaying the emblem of Swiss pharmaceutical big Roche in Basel.
SEBASTIEN BOZON | AFP | Getty Pictures
Drugmaker Roche on Friday mentioned it had obtained Emergency Use Authorization from the U.S. Meals and Drug Administration for a check to rapidly detect whether or not a affected person has SARS-CoV-2 or one in all two types of influenza
“With the approaching flu season, this new check is especially vital as SARS-CoV-2 and influenza infections can hardly be differentiated by signs alone. Now, with a single check, healthcare professionals can confidently present the appropriate prognosis and simplest remedy plan for his or her sufferers,” Roche diagnostics head Thomas Schinecker mentioned in an announcement.